Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Imipenem

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,492Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Primaxin

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Primaxin

    Imipenem

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck

    Imipenem

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 250

    2019 Revenue in Millions : 273

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Primaxin

    Imipenem and Cilastatin

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck

    Imipenem and Cilastatin

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 259

    2020 Revenue in Millions : 250

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Primaxin

    Imipenem

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck & Co.

    Imipenem

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 239

    2021 Revenue in Millions : 259

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Primaxin

    Imipenem

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck & Co.

    Imipenem

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 213

    2022 Revenue in Millions : 239

    Growth (%) : -11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Primaxin

    Imipenem and Cilastatin

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck & Co

    Imipenem and Cilastatin

    Main Therapeutic Indication : Anti-bacterial

    Currency : USD

    2015 Revenue in Millions : 329

    2014 Revenue in Millions : 313

    Growth (%) : -5%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Primaxin

    Imipenem and Cilastatin

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck & Co

    Imipenem and Cilastatin

    Main Therapeutic Indication : Anti-bacterial

    Currency : USD

    2014 Revenue in Millions : -1.80%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Primaxin

    Imipenem And Cilastatin

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck & Co.

    Imipenem And Cilastatin

    Main Therapeutic Indication : Anti-Bacterial

    Currency : USD

    2016 Revenue in Millions : 297

    2015 Revenue in Millions : 313

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Primaxin

    Imipenem and Cilastatin

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck & Co. Inc.

    Imipenem and Cilastatin

    Main Therapeutic Indication : Anti-bacterial

    Currency : USD

    2017 Revenue in Millions : 280

    2016 Revenue in Millions : 297

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Primaxin

    Imipenem And Cilastatin

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck & Co.

    Imipenem And Cilastatin

    Main Therapeutic Indication : Anti-Bacterial

    Currency : USD

    2018 Revenue in Millions : 265

    2017 Revenue in Millions : 280

    Growth (%) : -5%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Primaxin

    Imipenem

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Primaxin

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Merck

    Imipenem

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2019 Revenue in Millions : 273

    2018 Revenue in Millions : 265

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF